BioCentury
ARTICLE | Company News

Supernus sales and marketing update

September 16, 2013 7:00 AM UTC

Supernus launched Trokendi XR topiramate in the U.S. to treat epilepsy. The extended-release formulation of topiramate, which was approved last month, is available in 25, 50, 100 and 200 mg capsules....